By Dr Morag McFarlane
AS the unwavering commitment to vaccine development becomes the new norm, we find ourselves relying more heavily than ever before on volunteers and clinical trials.
The news of effective vaccines signalled a light at the end of the tunnel that the world had been yearning for since the coronavirus pandemic struck. It immediately became the trending topic on social media, news channels and outlets around the globe. The narrative was peppered with praise for the hard-working teams of scientists behind the breakthrough – and rightly so. Their efforts will undoubtedly save lives and bring an end to this challenging way of life that we’re facing – but what about those who put themselves forward for the clinical trials? The unsung heroes who stepped up to help rid the world of the virus?
“Thank goodness for the volunteers who helped to make this possible,” was not a phrase that we heard enough. While praised and acknowledged by some, the role of these volunteers – who found a way to play an essential role in progressing a monumental scientific discovery – was downplayed as this key battle against Covid-19 was being fought. They simply haven’t been celebrated in the same way. While there may be a feeling of "anyone can do that", the reality is that very few do.
We must work harder to eradicate the preconceived notion of "danger" surrounding clinical trials. Clinical trials are carried out every day and there is a well-defined framework in place for ensuring the safety of volunteers. Even before volunteers are called upon, the product has already undergone comprehensive research in accordance with the UK Government, as well as tests on animal and human tissue.
We must also work harder as an industry to highlight the opportunities available to take part in clinical trials, as it’s a key part of medical development and is likely much easier than you think.
Dr Morag McFarlane, CEO of The Intelligent Tissue Group
Covid-19 is not the only killer we’re faced with: cardiovascular disease, for example, is currently Scotland’s biggest cause of death.
As a Scottish company that runs clinical trials on behalf of clients through our Intelligent Clinical arm, we’re working to refocus research outside of Covid-19. However, this isn’t possible without volunteers. We encourage those who may be interested to join a database so they can be kept up to date with news about what clinical trials are taking place and why.
While you may be notified about specific trials (dependant on age, gender and health), signing-up remains optional and there is no pressure to take part.
The need to fuel the development of scientific research which will ultimately save lives is more important than ever before. This starts with those willing to step forward and do their bit.
It’s time that we recognised the vital role these volunteers play on behalf of all of us; their integral role in this pandemic must not be overlooked and certainly not forgotten.
Dr Morag McFarlane is CEO of The Intelligent Tissue Group
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here